- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
Patent holdings for IPC class A61K 31/137
Total number of patents in this class: 4873
10-year publication summary
|
404
|
416
|
443
|
444
|
474
|
456
|
412
|
388
|
321
|
271
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 378 |
224 |
| The Regents of the University of California | 20842 |
56 |
| Novartis AG | 10175 |
53 |
| Zogenix International Limited | 71 |
41 |
| Grünenthal GmbH | 523 |
40 |
| Nalpropion Pharmaceuticals LLC | 68 |
40 |
| Axsome Therapeutics, Inc. | 425 |
37 |
| Aquestive Therapeutics, Inc. | 186 |
29 |
| The Procter & Gamble Company | 21859 |
28 |
| Noven Pharmaceuticals, Inc. | 87 |
28 |
| Radius Pharmaceuticals, Inc. | 56 |
26 |
| Vanderbilt University | 2030 |
23 |
| Belhaven Biopharma, Inc. | 29 |
23 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3289 |
22 |
| The Trustees of Columbia University in the City of New York | 3649 |
21 |
| The United States Government AS represented by The Department of Veterans Affairs | 1338 |
21 |
| Nevakar Injectables Inc. | 38 |
21 |
| Gruenenthal GmbH | 94 |
20 |
| Ironshore Pharmaceuticals & Development, Inc. | 37 |
20 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
20 |
| Other owners | 4080 |